advertisement
11.4 Prostaglandins (16)
Showing records 1 to 16
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins51357 Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events
Tsumura T; Yoshikawa K; Suzumura H; Kimura T; Sasaki S; Kimura I; Takeda R
Clinical Ophthalmology 2012; 6: 1547-1552
51253 Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma
Inoue K; Iwasa M; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 1315-1319
51358 A randomized crossover study comparing tafluprost 0.0015% with travoprost 0.004% in patients with normal-tension glaucoma corrected
Mizoguchi T; Ozaki M; Unoki K; Dake Y; Eto T; Arai M
Clinical Ophthalmology 2012; 6: 1579-1584
51187 Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma
Taylor SR; Gurbaxani A; Sallam A; Lightman S
Open Ophthalmology Journal 2012; 6: 75-78
51230 Longitudinal effect of topical antiglaucoma medications on central corneal thickness
Viswanathan D; Goldberg I; Graham SL
Clinical and Experimental Ophthalmology 2013; 41: 348-354
51290 Repeatability of measurements of effectiveness of glaucoma medication
Rotchford AP; King AJ
British Journal of Ophthalmology 2012; 96: 1494-1497
51391 Efficacy and Tolerability of Preservative-free Tafluprost 0.0015 % in the Treatment of Glaucoma and Ocular Hypertension
Karhanová M; Mlčák P; Fryšák Z; Marešová K
Česka a Slovenska Oftalmologie 2012; 68: 150-155
51193 Deepening of the Upper Eyelid Sulcus Caused by 5 Types of Prostaglandin Analogs
Inoue K; Shiokawa M; Wakakura M; Tomita G
Journal of Glaucoma 2013; 22: 626-631
51158 Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure
Tung JD; Tafreshi A; Weinreb RN; Slight JR; Medeiros FA; Liu JH
BMJ open 2012; 2:
50808 Effects of corneal thickness on the intraocular penetration of travoprost 0.004%
Martinez-de-la-Casa JM; Rayward O; Saenz-Frances F; Santos-Bueso E; Mendez-Hernandez C; Herrero-Vanrell R; Garcia-Feijoo J; Garcia-Sanchez J
Eye 2012; 26: 972-975
51286 The United Kingdom Glaucoma Treatment Study: A Multicenter, Randomized, Placebo-Controlled Clinical Trial: Design and Methodology
Garway-Heath DF; Lascaratos G; Bunce C; Crabb D; Russell R; Shah A;
Ophthalmology 2013; 120: 68-76
51206 Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy
Sira M; Verity DH; Malhotra R
Aesthetic surgery journal / the American Society for Aesthetic Plastic surgery 2012; 32: 822-824
51167 Incidence of Deepening of the Upper Eyelid Sulcus After Topical Use of Travoprost Ophthalmic Solution in Japanese
Maruyama K; Shirato S; Tsuchisaka A
Journal of Glaucoma 2014; 23: 160-163
51069 Dual effect of prostaglandins on isolated intraocular porcine ciliary arteries
Kringelholt S; Simonsen U; Bek T
Acta Ophthalmologica 2013; 91: 498-504
50876 Intraocular pressure-lowering combination therapies with prostaglandin analogues
Aptel F; Chiquet C; Romanet JP
Drugs 2012; 72: 1355-1371
51044 Investigation of surfactants suitable for stabilizing of latanoprost
Ochiai A; Ohkuma M; Danjo K
International Journal of Pharmaceutics 2012; 436: 732-737
